[1]罗霞, 陈春来, 周静. 缩宫素、地诺前列酮栓及宫颈扩张球囊在妊娠晚期引产中的疗效比较[J].中国生化药物杂志,2016,36(4):71-73.
[2]庞磊,孙小婷,魏骐,等.前列腺素受体EP4在心肌肥厚和心肌缺血/再灌注损伤中作用的研究进展[J].吉林大学学报(医学版),2016,42(6):1249-1253.
[3]廖聪.宫颈扩张球囊与前列腺素类制剂促宫颈成熟引产效果比较[J].现代仪器与医疗,2016,22(2):78-80.
[4]郑飞,于慧敏,高丽.氟比洛芬酯在子宫肌瘤患者体内的药物代谢分布及对前列腺素E2的影响[J].中国生化药物杂志,2016,36(12):63-65.
[5]中华医学会妇产科学分会产科学组.妊娠晚期促子宫颈成熟与引产指南(2014)[J].中华妇产科杂志,2014,49(12):881-885.
[6]王治荣,公丕军.促宫颈成熟球囊引产疗效及对分娩与新生儿结局的影响[J].检验医学与临床,2016,13(19):2772-2774.
[7]刘振荣,谢娟.人工破膜术对分娩结局及母婴的影响[J].长春中医药大学学报,2015,31(6):1285-1287.
[8]杨雯,曹友玲,宋晓婕.欣普贝生与COOK球囊用于足月妊娠初产妇引产对比观察[J].山东医药,2015,55(19):56-58.
[9]赵淑芯,赵鑫鑫,王贻英.地诺前列酮和双球囊导管在羊水过少产妇引产中的应用[J].实用妇产科杂志,2015,31(8):628-630.
[10]Shechter-Maor G,Haran G,Sadeh-Mestechkin D, et al. Intra-vaginal prostaglandin E2 versus double-balloon catheter for labor induction in term oligohydramnios[J]. J Perinatol, 2015, 35(2):95-98.
[11]Kehl S,Weiss C,Wamsler M, et al. Double-balloon catheter and sequential vaginal prostaglandin E2 versus vaginal prostaglandin E2 alone for induction of labor after previous cesarean section[J]. Arch Gynecol Obstet, 2015, 293(4):757-765.
[12]沈梅,孙波,赵卫华,等.Cook子宫颈扩张球囊与欣普贝生用于足月妊娠引产的临床研究[J].中国妇幼保健,2015,35(4):624-627.
[13]石明宏,程节凤,王琍,等.COOK宫颈扩张球囊、地诺前列酮、缩宫素对妊娠期糖尿病孕妇促宫颈成熟的效果[J].广州医科大学学报,2015,43(6):33-37.
[14]王晓宇,李斌,范颖.双球囊扩张、欣普贝生及催产素促宫颈成熟的疗效及安全性比较[J].山东医药,2014,54(16):72-74.
[15]Mizrachi Y,Levy M,Weiner E, et al. Pregnancy outcomes after failed cervical ripening with prostaglandin E2 followed by Foley balloon catheter[J]. J Matern Fetal Neonatal Med, 2016, 29(19):3229-3261.
[16]Agboghoroma CO,Ngonadi N. A randomized controlled study comparing Prostaglandin E2 vaginal suppository with intra-cervical Foleys catheter balloon for preinduction cervical ripening at term[J]. West Afr J Med, 2015, 34(2):77-82. |